Cryopreserved ampule of Human Peripheral Blood Mononuclear Cells (hPBMC) containing ≥ 25 million cells
Culture system containing required basal medium and supplements for hMSC osteogenic differentiation
Cryopreserved ampule of Human Peripheral Blood Mononuclear Cells (hPBMC) containing ≥ 50 million cells with cell population frequency information
Cryopreserved ampule of Human Peripheral Blood Mononuclear Cells (hPBMC) containing ≥ 100 million cells
Do you need a modified version of this cell product, such as different vialing sizes, matched immune cell isolations or isolations from special donors or species? Contact Lonza CellBio Services to discuss custom isolation, expansion, and testing options for your research
Cryopreserved ampule of Human Peripheral Blood Mononuclear Cells (hPBMC) containing ≥ 25 million cells
Do you need a modified version of this cell product, such as different vialing sizes, matched immune cell isolations or isolations from special donors or species? Contact Lonza CellBio Services to discuss custom isolation, expansion, and testing options for your research
Cryopreserved ampule of Human Peripheral Blood Mononuclear Cells (hPBMC) containing ≥ 10 million cells
Do you need a modified version of this cell product, such as different vialing sizes, matched immune cell isolations or isolations from special donors or species? Contact Lonza CellBio Services to discuss custom isolation, expansion, and testing options for your research
Culture system containing hMSC Chondrogenic Basal Medium (PT-3925) and hMSC Chondrogenic SingleQuotsTM Kit Supplement (PT-4121) required for hMSC chondrogenic differentiation
-
siRNA Transfection Protocol for Blood LymphocytesInstructions of use for transfection of human peripheral blood lympohocytes with siRNA using the Nucleofector™ Technology
-
Predicting Antibody Dependent Cell-Mediated Cytotoxicity (ADCC)Genotypic and Phenotypic Screening of Human Peripheral Blood Mononuclear Cells
-
Transfection Protocol for Human T Cells (Stim.) - HT Nucleofector™ DeviceInstructions of use for transfection of stimulated peripheral blood human T cells with the P3 Primary Cell HT-Nucleofector™ Kit
-
Transfection Protocol for Human T Cells (Stim.) - 4D-Nucleofector™ DeviceInstructions of use for transfection of stimulated peripheral blood human T cells with the P3 Primary Cell 4D-Nucleofector™ X Kit
-
Transfection Protocol for Human T Cells (Unstim.) - 4D-Nucleofector™ DeviceInstructions of use for transfection of unstimulated peripheral blood human T cells with the P3 Primary Cell 4D-Nucleofector™ X Kit
-
Transfection Protocol for Human T Cells (Stim.) - 96-well Shuttle™ DeviceInstructions of use for transfection of stimulated peripheral blood human T cells with the P3 Primary Cell 96-well Nucleofector™ Kit
-
Transfection Protocol for Human T Cells (Unstim.) - 96-well Shuttle™ DeviceInstructions of use for transfection of unstimulated peripheral blood human T cells with the P3 Primary Cell 96-well Nucleofector™ Kit
-
Transfection Protocol for Human T Cells (Unstim.) - 4D-Nucleofector™ LV UnitInstructions of use for transfection of unstimulated peripheral blood human T cells with the P3 Primary Cell 4D-Nucleofector™ LV Kit
-
Generation of hiPSCs from Cord Blood Cells With the 4D-Nucleofector® SystemA scientific paper by Lonza, outlining the generation of iPSCs from Cord Blood Cells using the 4D-Nucleofector® System
-
Normal Peripheral Blood CD4+ T LymphocytesLonza Application Notes